Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD

Clinical trial NCT05454956 · COMPLETED

Trial details

NCT number: NCT05454956
Sponsor: Tarsus Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meibomian Gland Dysfunction Blepharitis Demodex Infestation

Start date: 2022-08-03
Primary completion: 2023-05-18
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.